Search
  1. Home
  2. East Africa
  3. Kenya

Cosmos clinches another AIDS drug deal

    JOHANNESBURG

    The Kenyan drug firm, Cosmos, has been granted a license by German pharmaceutical giant Boehringer Ingelheim to produce generic versions of its patented anti-AIDS drug, Nevirapine, for resale across east Africa and in Rwanda and Burundi.

    Cosmos will produce Nevirapine in combination with other anti-AIDS drugs and also as a single-dose medication for the prevention of mother-to-child transmission (PMTCT) of HIV.

    Nevirapine is still widely used in single-dose form for PMTCT, despite fears that the drug could create resistance in some HIV-positive expectant mothers.

    The Associate Press quoted Cosmos managing director Prakesh Patel as saying: "We will start producing Nevirapine within two to three weeks."

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join